Summary of HR 9017 (119th Congress)
Purpose and intent
- HR 9017 seeks to provide that compliance with a specified biological opinion constitutes compliance with the Endangered Species Act (ESA) requirements for a particular agency action. In other words, if an agency action adheres to the terms of a defined biological opinion, that action would be considered in compliance with the ESA for the purposes of that action.
Key provisions and changes
- Establishes a link between a biological opinion and ESA compliance:
- When an agency follows the recommendations and determinations laid out in a certain biological opinion, that adherence would be treated as meeting the ESA’s substantive requirements for the related agency action.
- Aims to streamline or clarify process by potentially reducing the need for separate ESA compliance review where a compliant biological opinion already covers ESA obligations for the action in question.
- The bill’s text would specify the scope, the particular agency action(s) involved, and the precise biological opinion referenced (the bill as introduced would need to be consulted for the exact naming and scope).
Who or what would be affected
- Federal agencies undertaking the specified agency action linked to the biological opinion (likely actions tied to environmental or resource management, given the ESA context).
- Stakeholders include:
- Federal agencies responsible for endangered species protections and habitat management
- Entities subject to agency actions (e.g., permittees, project developers, or other regulated parties) who rely on ESA and wildlife conservation compliance
- Conservation groups and other stakeholders interested in ESA implementation and biological opinions
Procedural and timeline aspects
- Introduced in the House and referred on May 22, 2026, to:
- Committee on Transportation and Infrastructure
- Committee on Natural Resources
for consideration of provisions within their jurisdiction
- The date indicates initial stage in the legislative process; as with many bills, subsequent steps would include committee hearings, potential amendments, and floor consideration in the House, followed by movement through the Senate (if it advances).
Additional context
- Co-sponsors include Mike Haridopolos, Vern Buchanan, Jared Moskowitz, Byron Donalds, and Brian Mast, signaling bipartisan interest in addressing how biological opinions interact with ESA compliance for agency actions.
- The bill’s effectiveness and practical impact would depend on the specific biological opinion referenced, the exact agency action covered, and how courts interpret the interplay between a compliant biological opinion and ESA requirements.
If you’d like, I can pull the full text to extract precise language, identify the exact biological opinion and agency actions covered, and note any sunset provisions, funding implications, or reporting requirements.
Start the Conversation
Be the first to share your thoughts on this petition. Your voice matters!